US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 20.000
  • +0.650+3.36%
Close Mar 4 16:00 ET
  • 20.000
  • 0.0000.00%
Post 19:14 ET
1.33BMarket Cap-8.16P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.06%-157.78M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
-3.43%-107.29M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.2M
-16.45%-28.57M
Net income from continuing operations
-11.62%-157.86M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
Operating gains losses
--16K
--4K
--4K
--0
--8K
----
----
----
----
----
Depreciation and amortization
5.62%3.18M
7.91%819K
2.48%786K
5.42%797K
6.75%775K
3.87%3.01M
12.78%759K
14.31%767K
2.02%756K
-10.48%726K
Change In working capital
-260.46%-21.6M
48.08%7.38M
-248.34%-19.29M
286.99%2.82M
-314.25%-12.5M
445.36%13.46M
7,563.08%4.98M
195.79%13.01M
-109.85%-1.51M
46.90%-3.02M
-Change in receivables
184.52%1.93M
106.40%152K
608.96%682K
-4.93%1.14M
95.55%-43K
-1,203.43%-2.28M
-1,403.80%-2.38M
-45.65%-134K
719.18%1.2M
-1,261.97%-967K
-Change in prepaid assets
-437.07%-19.89M
-98.21%74K
-889.38%-14.35M
121.52%599K
-328.10%-6.21M
161.64%5.9M
352.01%4.14M
226.39%1.82M
-108.15%-2.78M
138.08%2.72M
-Change in payables and accrued expense
23.98%11.63M
106.19%7.99M
-20.88%6.71M
258.58%1.71M
-38.66%-4.78M
200.48%9.38M
61.34%3.88M
163.18%8.48M
-97.17%478K
-25.93%-3.45M
-Change in other current assets
-321,233.33%-9.64M
--0
---9.64M
----
----
---3K
--0
--0
----
----
-Change in other current liabilities
-1,319.91%-5.64M
-27.30%-844K
-194.59%-2.69M
-60.00%-632K
-10.87%-1.47M
-83.05%462K
-23.69%-663K
555.93%2.85M
-2.07%-395K
-131.01%-1.33M
Cash from discontinued investing activities
Operating cash flow
-47.06%-157.78M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
-3.43%-107.29M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.2M
-16.45%-28.57M
Investing cash flow
Cash flow from continuing investing activities
-174.27%-290.13M
114.05%24.05M
310.08%47.76M
-4,114.00%-46.72M
-699.61%-315.21M
-217.61%-105.78M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
Net PPE purchase and sale
-5.56%-1.92M
-13.51%-756K
-247.13%-545K
33.17%-274K
41.20%-344K
0.55%-1.82M
-183.40%-666K
54.49%-157K
39.08%-410K
-1.74%-585K
Net investment purchase and sale
-177.22%-288.21M
114.55%24.8M
309.24%48.3M
-3,051.02%-46.45M
-692.37%-314.87M
-213.37%-103.96M
-642.15%-170.5M
-49.44%11.8M
-93.94%1.57M
385.20%53.15M
Cash from discontinued investing activities
Investing cash flow
-174.27%-290.13M
114.05%24.05M
310.08%47.76M
-4,114.00%-46.72M
-699.61%-315.21M
-217.61%-105.78M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
Financing cash flow
Cash flow from continuing financing activities
102.07%441.45M
-99.82%386K
382.10%1.24M
2,690.98%3.71M
62,740.35%436.11M
5,259.62%218.46M
15,482.37%217.37M
-88.86%257K
87.32%133K
128.29%694K
Net common stock issuance
99.93%432.3M
--0
--0
--0
--432.3M
--216.22M
--216.22M
--0
--0
--0
Proceeds from stock option exercised by employees
309.26%9.15M
-66.49%386K
382.10%1.24M
2,690.98%3.71M
449.57%3.81M
-45.14%2.24M
-17.42%1.15M
-88.86%257K
87.32%133K
128.29%694K
Cash from discontinued financing activities
Financing cash flow
102.07%441.45M
-99.82%386K
382.10%1.24M
2,690.98%3.71M
62,740.35%436.11M
5,259.62%218.46M
15,482.37%217.37M
-88.86%257K
87.32%133K
128.29%694K
Net cash flow
Beginning cash position
18.30%34.81M
72.23%36.4M
51.43%42.74M
112.62%115.08M
18.30%34.81M
-24.82%29.43M
13.73%21.13M
-0.62%28.22M
113.98%54.12M
-24.82%29.43M
Current changes in cash
-219.93%-6.46M
-158.79%-8.04M
10.58%-6.34M
-179.31%-72.34M
225.03%80.26M
155.44%5.39M
26.13%13.68M
27.79%-7.09M
-933.30%-25.9M
278.30%24.69M
End cash Position
-18.55%28.36M
-18.55%28.36M
72.23%36.4M
51.43%42.74M
112.62%115.08M
18.30%34.81M
18.30%34.81M
13.73%21.13M
-0.62%28.22M
113.98%54.12M
Free cash flow
-46.36%-159.7M
-0.10%-33.23M
-191.81%-55.88M
-7.23%-29.6M
-40.57%-40.98M
-3.36%-109.11M
-50.93%-33.2M
46.11%-19.15M
-20.46%-27.61M
-16.11%-29.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.06%-157.78M0.18%-32.48M-191.35%-55.34M-7.84%-29.33M-42.25%-40.64M-3.43%-107.29M-49.49%-32.53M46.03%-18.99M-22.26%-27.2M-16.45%-28.57M
Net income from continuing operations -11.62%-157.86M-8.74%-47.09M-10.09%-42.12M-17.51%-35.84M-11.74%-32.81M-25.91%-141.43M-63.50%-43.31M-42.85%-38.26M15.28%-30.5M-27.38%-29.36M
Operating gains losses --16K--4K--4K--0--8K--------------------
Depreciation and amortization 5.62%3.18M7.91%819K2.48%786K5.42%797K6.75%775K3.87%3.01M12.78%759K14.31%767K2.02%756K-10.48%726K
Change In working capital -260.46%-21.6M48.08%7.38M-248.34%-19.29M286.99%2.82M-314.25%-12.5M445.36%13.46M7,563.08%4.98M195.79%13.01M-109.85%-1.51M46.90%-3.02M
-Change in receivables 184.52%1.93M106.40%152K608.96%682K-4.93%1.14M95.55%-43K-1,203.43%-2.28M-1,403.80%-2.38M-45.65%-134K719.18%1.2M-1,261.97%-967K
-Change in prepaid assets -437.07%-19.89M-98.21%74K-889.38%-14.35M121.52%599K-328.10%-6.21M161.64%5.9M352.01%4.14M226.39%1.82M-108.15%-2.78M138.08%2.72M
-Change in payables and accrued expense 23.98%11.63M106.19%7.99M-20.88%6.71M258.58%1.71M-38.66%-4.78M200.48%9.38M61.34%3.88M163.18%8.48M-97.17%478K-25.93%-3.45M
-Change in other current assets -321,233.33%-9.64M--0---9.64M-----------3K--0--0--------
-Change in other current liabilities -1,319.91%-5.64M-27.30%-844K-194.59%-2.69M-60.00%-632K-10.87%-1.47M-83.05%462K-23.69%-663K555.93%2.85M-2.07%-395K-131.01%-1.33M
Cash from discontinued investing activities
Operating cash flow -47.06%-157.78M0.18%-32.48M-191.35%-55.34M-7.84%-29.33M-42.25%-40.64M-3.43%-107.29M-49.49%-32.53M46.03%-18.99M-22.26%-27.2M-16.45%-28.57M
Investing cash flow
Cash flow from continuing investing activities -174.27%-290.13M114.05%24.05M310.08%47.76M-4,114.00%-46.72M-699.61%-315.21M-217.61%-105.78M-648.36%-171.16M-49.51%11.65M-95.40%1.16M406.45%52.57M
Net PPE purchase and sale -5.56%-1.92M-13.51%-756K-247.13%-545K33.17%-274K41.20%-344K0.55%-1.82M-183.40%-666K54.49%-157K39.08%-410K-1.74%-585K
Net investment purchase and sale -177.22%-288.21M114.55%24.8M309.24%48.3M-3,051.02%-46.45M-692.37%-314.87M-213.37%-103.96M-642.15%-170.5M-49.44%11.8M-93.94%1.57M385.20%53.15M
Cash from discontinued investing activities
Investing cash flow -174.27%-290.13M114.05%24.05M310.08%47.76M-4,114.00%-46.72M-699.61%-315.21M-217.61%-105.78M-648.36%-171.16M-49.51%11.65M-95.40%1.16M406.45%52.57M
Financing cash flow
Cash flow from continuing financing activities 102.07%441.45M-99.82%386K382.10%1.24M2,690.98%3.71M62,740.35%436.11M5,259.62%218.46M15,482.37%217.37M-88.86%257K87.32%133K128.29%694K
Net common stock issuance 99.93%432.3M--0--0--0--432.3M--216.22M--216.22M--0--0--0
Proceeds from stock option exercised by employees 309.26%9.15M-66.49%386K382.10%1.24M2,690.98%3.71M449.57%3.81M-45.14%2.24M-17.42%1.15M-88.86%257K87.32%133K128.29%694K
Cash from discontinued financing activities
Financing cash flow 102.07%441.45M-99.82%386K382.10%1.24M2,690.98%3.71M62,740.35%436.11M5,259.62%218.46M15,482.37%217.37M-88.86%257K87.32%133K128.29%694K
Net cash flow
Beginning cash position 18.30%34.81M72.23%36.4M51.43%42.74M112.62%115.08M18.30%34.81M-24.82%29.43M13.73%21.13M-0.62%28.22M113.98%54.12M-24.82%29.43M
Current changes in cash -219.93%-6.46M-158.79%-8.04M10.58%-6.34M-179.31%-72.34M225.03%80.26M155.44%5.39M26.13%13.68M27.79%-7.09M-933.30%-25.9M278.30%24.69M
End cash Position -18.55%28.36M-18.55%28.36M72.23%36.4M51.43%42.74M112.62%115.08M18.30%34.81M18.30%34.81M13.73%21.13M-0.62%28.22M113.98%54.12M
Free cash flow -46.36%-159.7M-0.10%-33.23M-191.81%-55.88M-7.23%-29.6M-40.57%-40.98M-3.36%-109.11M-50.93%-33.2M46.11%-19.15M-20.46%-27.61M-16.11%-29.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+9.66%
Coinbase
COIN
+3.30%
Alphabet-A
GOOGL
+2.34%
Alphabet-C
GOOG
+2.34%
NVIDIA
NVDA
+1.69%

Unlock the Full List